carboplatin,etoposide,atezolizumab,tiragolumab
roche
['skyscraper-02', 'lcsm,(-blcsm)', 'atezo', 'tiragolumab', 'sclc']
time for anti-tigit skyscraper-02 phase iii trial of tiragolumab in combination with chemo-atezolizumab in 1l sclc. negative trial, but remarkable 13.6m mos, a landamark for this devastating disease. #asco22 #lcsm 
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm